Recent Posts
- Chronic hypoparathyroidism issues show need for screening, treatment
- TransCon PTH improves kidney function at 2 years in PaTHway trial
- FDA delays decision on TransCon PTH for hypoparathyroidism
- Eneboparatide, now in Phase 3 trial, placed on fast track by FDA
- Hypoparathyroidism tied to cancer-related thyroidectomy mortality
- Impaired kidney function is common in hypoparathyroidism
- Yorvipath for adult patients now available in Germany and Austria
- High body fat may protect against hypoparathyroidism after surgery
- TransCon PTH approved in Europe as Yorvipath, under review in U.S.
- 1st reported use of Natpara in early pregnancy detailed in case study